Chen, C.-H.;                     Lin, Y.-J.;                     Cheng, L.-T.;                     Lin, C.-H.;                     Ke, G.-M.    
        Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling. Vaccines 2022, 10, 715.
    https://doi.org/10.3390/vaccines10050715
    AMA Style
    
                                Chen C-H,                                 Lin Y-J,                                 Cheng L-T,                                 Lin C-H,                                 Ke G-M.        
                Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling. Vaccines. 2022; 10(5):715.
        https://doi.org/10.3390/vaccines10050715
    
    Chicago/Turabian Style
    
                                Chen, Chao-Hung,                                 Yu-Jen Lin,                                 Li-Ting Cheng,                                 Chien-Hung Lin,                                 and Guan-Ming Ke.        
                2022. "Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling" Vaccines 10, no. 5: 715.
        https://doi.org/10.3390/vaccines10050715
    
    APA Style
    
                                Chen, C.-H.,                                 Lin, Y.-J.,                                 Cheng, L.-T.,                                 Lin, C.-H.,                                 & Ke, G.-M.        
        
        (2022). Poloxamer-188 Adjuvant Efficiently Maintains Adaptive Immunity of SARS-CoV-2 RBD Subunit Vaccination through Repressing p38MAPK Signaling. Vaccines, 10(5), 715.
        https://doi.org/10.3390/vaccines10050715